Search

everythinglearnresearchcommunity

for

Search:↓

Dutasteride, usually used for prostate issues and hair loss, could potentially treat Amyotrophic Lateral Sclerosis (ALS) due to its neuroprotective, antioxidant, and anti-inflammatory properties, but more testing is needed.

PDGF-D boosts stem cell growth and movement, enhancing hair regeneration.

5alpha-DHP may be a safe, effective treatment for certain seizures without causing sedation.

Haloperidol decanoate can cause alopecia areata.

Ponatinib can cause a rare skin reaction that resolves with topical treatment and temporary drug discontinuation.

AD198 is more effective than doxorubicin in stopping certain dog cancer cells.

2-DG reduces seizures by enhancing brain inhibition through specific receptor activation.

DFMO may help control hair growth and treat cancer.

Dutasteride may protect brain cells in early Parkinson's, while progesterone helps neuron recovery.

Topical immunotherapy, especially with DPCP, is effective for treating severe alopecia areata.

High-dose dutasteride reduces PMDD symptoms by stabilizing neurosteroid levels.

Prostaglandin E2 helps prevent hair loss from radiotherapy by protecting hair growth cells and aiding self-repair.

Diphenylcyclopropenone (DPCP) can help regrow hair in many alopecia areata patients but may cause side effects and relapses.

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

Finasteride may help improve certain brain function issues linked to dopamine.

Pazopanib treatment caused rapid hair color loss, possibly indicating its effectiveness.

Dutasteride effectively treats benign prostatic hyperplasia and may reduce prostate cancer risk.

Diphenylcyclopropenone (DPCP) effectively treated both alopecia areata and verruca vulgaris.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

Combining imiquimod with diphenylcyclopropenone may improve treatment outcomes for alopecia areata patients who don't respond to diphenylcyclopropenone alone.

Dupilumab significantly improved a 5-year-old girl's prurigo nodularis without side effects.

Delta-opioid receptors affect skin cell circadian rhythms, possibly impacting wound healing and cancer.

Dutasteride reduces DHT and improves BPH symptoms more effectively than finasteride.

Diphenylcyclopropenone treatment helps hair growth in alopecia areata by promoting blood vessel growth and cell survival.

Inhibitors of 11β-HSD1 show potential for treating type 2 diabetes but require more testing for safety and effectiveness.

Blocking DPP4 can help activate hair growth and improve hair regeneration.

The document concludes that adenosine receptor agonists have potential for treating various conditions, but only a few are approved due to challenges like side effects and the need for selective activation.

Dopamine agonists like pramipexole and ropinirole can cause reversible hair loss.